Articles tagged under: Elanco Animal Health
Elanco Spins Off Coccidiosis Product to Merck Animal Health
Published February 20, 2020
Elanco Animal Health has signed an agreement with Merck Animal Health to divest its rights to Vecoxan, which is used to treat coccidiosis in calves and lambs. The all-cash deal totals $55 million. This agreement is contingent on Elanco closing…A Major Deal in the Animal Health Business
Published August 20, 2019
Elanco Animal Health has an agreement to acquire Bayer Animal Health. This deal, which still needs regulatory approval, is valued at $7.6 billion.Elanco Makes Acquisition
Published August 2, 2019
Elanco Animal Health has acquired a Canadian biotechnology firm called Prevtec Microbia. Prevtec Microbia develops vaccines to help prevent bacterial diseases in food animals. The deal was valued at $60 million.